PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsCurcumin
Curcumin
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
995 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Type 2 diabetes mellitusD003924EFO_0001360E1151193932
NeoplasmsD009369—C8018821431
Diabetes mellitusD003920EFO_0000400E08-E1357611025
Hiv infectionsD015658EFO_0000764B209271119
Hepatitis cD006526—B19.28812—18
HepatitisD006505—K75.99314117
Postpartum hemorrhageD006473—O72—124915
SyndromeD013577——23—11015
Chronic hepatitis bD019694EFO_0004239B18.13324214
Hepatitis aD006506EFO_0007305B157214114
Show 81 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C507145—933
InflammationD007249MP_0001845—242—2532
Prostatic neoplasmsD011471—C61572—417
Covid-19D000086382—U07.1—36—916
Colorectal neoplasmsD015179——762—215
LymphomaD008223—C85.9691——14
Cognitive dysfunctionD060825—G31.84251—714
Kidney diseasesD007674EFO_0003086N08153—513
Chronic renal insufficiencyD051436—N18244—413
OsteoarthritisD010003EFO_0002506M15-M19224—713
Show 136 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———503——2375
Alzheimer diseaseD000544EFO_0000249F0324——813
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.933——511
AsthmaD001249EFO_0000270J4524——28
Neoplasm metastasisD009362EFO_0009708—54———7
Non-small-cell lung carcinomaD002289——53——17
Postoperative painD010149—G89.18—1——67
RecurrenceD012008——43——17
Lung diseasesD008171EFO_0003818J98.413——37
Coronary artery diseaseD003324—I25.112——47
Show 165 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OverweightD050177—E66.32———57
Autism spectrum disorderD000067877—F84.01———45
DementiaD003704EFO_0003862F031———34
Autistic disorderD001321EFO_0003758F84.01———34
PharmacokineticsD010599——2———13
Central nervous system neoplasmsD016543——1———23
Autoimmune diseasesD001327EFO_0000540M30-M361———23
Hiv-1D015497——2————2
Memory disordersD008569——1———12
SarcomaD012509——1———12
Show 61 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AtherosclerosisD050197EFO_0003914I25.1————66
Iron deficienciesD000090463—E61.1————55
Iron-deficiency anemiaD018798—D50————44
Motor activityD009043EFO_0003940—————44
Healthy dietD000072001——————33
Anxiety disordersD001008EFO_0006788F41.1————33
Wound healingD014945GO_0042060—————33
AdenomaD000236——————22
PhenylketonuriasD010661—E70.0————22
Male infertilityD007248EFO_0004248N46————22
Show 244 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,885 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use